Tall Allen said...
Whattheheck-
Yes, bone scans are confusing. So are NaF scans. They tell you what areas have bone overgrowth or active bone growth, but may not be specific for prostate cancer. There are other PET scans that are more specific, but are expensive or not available everywhere. Bone biopsies are invasive and they aren't always in convenient places. The easiest way to sort out what is a bone met from what isn't is to simply wait a couple of months and re-do the scans. If the lesions are related to prostate cancer, they will shrink. Otherwise, they won't. Waiting a couple of months while you're on Lupron is safe - the cancer won't grow.
As for next steps, there's no one right approach. Here is a discussion of the several options. Note that Zytiga is no less toxic than docetaxel if used at this point:
Newly diagnosed, metastatic (M1), but still hormone sensitive - best options
Will your insurance cover a consultation with a medical oncologist in Las Vegas? If so, talk to Nicholas Vogelzang - one of the best anywhere.
Hello Tall Allen,
Thank you so much for the info. It turns out that Dr. Nicholas Vogelzang is in my PPO network. I just need to have an appointment and then travel to Las Vegas. I'll call them tomorrow to see if and how soon I can be seen by him. At 450 miles away, Las Vegas isn't very convenient for repeat/regular visits but if it means I am seen by one of the best, it's probably worth it.
As to your suggestion of another scan in a couple of months to see if the lesions get smaller, I was worried about
waiting since so many of the newer treatments for mHSPC that I read say "when started early..." You seem to be suggesting that a couple months taking Lupron by itself won't matter, regardless of what the final DX and treatment plan turns out to be. I just want to be sure I am not missing a window of opportunity.
I read the blog link you provided about
treatment options and I was confused by the statement under the heading "Which Is Best?" It says, "No-Brainer -Zometa + Celebrex." Then, following the embedded link to Zometa + Celebrex, at the end of that link it says:
"The discussant for the session, A. Oliver Sartor, MD, of Tulane University Cancer Center in New Orleans, said that he doubted there will be attempts to replicate these results going forward. “I just suspect this combination is unlikely to become standard of care going forward,” he said."
I am confused by that since there didn't seem to be enough info to understand what he was basing that on. Your comments/clarifications will be appreciated.
Here is another question:
What are your thoughts about
including RT (brachytherapy+other local plus any mets) along with the other (ADT+Docetaxel or ADT+Zytiga or???) therapies? This could be regardless of the DX but assuming it is metastatic, I have read and I know there are some trials looking at radiation of the mother tumor, the pelvic area and any bone mets along with other ADT and/or Chemo therapies.
If I am not metastatic, the brachytherapy+other local Rad along with Lupron seems a reasonable path anyway. Please keep in mind that both extracapsular and 1 node involvement are also undetermined, though suspected. Do you agree that I should see a Rad Onc as well and if so who and with what in mind?
At this point, both my MO and Urologist are pretty sure I have bone mets and they want to start more aggressive treatment ASAP but it's hard to just trust. Even then, with them it's only a question of Lupron + Docetaxel or Lupron + Zytiga although my Urologist would support adding the RT idea above, while the MO didn't seem to like the idea much.
Sorry to take up so much time but I am sure you understand where I am at. Thanks again!